相关实验视频

Updated: Jul 2, 2025

Method for Measurement of Viral Fusion Kinetics at the Single Particle Level

Method for Measurement of Viral Fusion Kinetics at the Single Particle Level

Published on: September 7, 2009

膜融合抑制剂对不同血凝素亚型的有效性:从分子动力学模拟角度的洞察力

Nadtanet Nunthaboot¹, Thitiya Boonma¹, Chananya Rajchakom¹

¹Multidisciplinary Research Unit of Pure and Applied Chemistry and Supramolecular Chemistry Research Unit, Department of Chemistry and Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Mahasarakham University, Maha Sarakham, Thailand.

Journal of biomolecular structure & dynamics

|February 28, 2024

概括

新的抗流感药物CBS1117和JNJ4796对第一组血凝 (HA) 流感病毒的结合比第二组HA更强. 这种分子洞察力有助于开发更好的HA融合抑制剂来治疗流感.

科学领域:

病毒学和药物发现
结构生物学和分子建模

背景情况:

流感病毒对全球健康构成重大挑战,需要超越疫苗的新型治疗策略.
药物耐药性和疫苗开发的障碍推动了寻找新的抗流感药物的研究,这些药物针对的病毒蛋白,如血凝素 (HA).

研究的目的:

调查聚变抑制剂CBS1117和JNJ4796对流感HA的分子结合机制和组特异性.
阐明控制这些抑制剂对第1组 (H5) 和第2组 (H3) HA亚型的功率差异的原子相互作用.

主要方法:

用分子动力学模拟来分析CBS1117和JNJ4796与H5 HA和H3 HA的结合相互作用.
在HA结合口袋内确定和比较了关键残留物和非共价相互作用 (键,性相互作用).

主要成果:

与2组H3HA相比,CBS1117和JNJ4796与1组H5HA的相互作用显著更强.
稳定结合和涉及特定残留物的疏水相互作用在H5联体复合物中突出,但在H3抑制剂复合物中减弱.
预测的结合自由能量与实验数据相关,证实了抑制剂对第1组HA的偏好.

结论:

这项研究揭示了不同的分子结合机制,这些机制是CBS1117和JNJ4796对流感HA亚型的差异性疗效的基础.
这些发现为优化现有的HA融合抑制剂和设计针对特定HA组的新型抗流感疗法提供了关键的见解.

关键词:

在CBS111717中获得.血凝素是血液中的一个组成部分.JNJ479696 是一个很好的选择.有约束力的自由能源.核聚变抑制剂核聚变抑制剂分子动力学模拟模拟

更多相关视频

A Model Membrane Platform for Reconstituting Mitochondrial Membrane Dynamics

A Model Membrane Platform for Reconstituting Mitochondrial Membrane Dynamics

Published on: September 2, 2020

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

相关概念视频

SNAREs and Membrane Fusion

SNAREs and Membrane Fusion

Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...